Predictors of Health Literacy in Adults With Cystic Fibrosis

May 9, 2026 updated by: Aydan Aslı Aksel Uylar, Hacettepe University
The purpose of this study investigation of relationship between health literacy and physical activity, anxiety and depression, adherence to airway clearance techniques in adult patients with cystic fibrosis.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The assessment will begin with demographic information then health literacy, depression and anxiety and physical activity level will evaluation with related questionnaires.

Study Type

Observational

Enrollment (Actual)

62

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Cystic fibrosis participants between 18-65 years old.

Description

Inclusion Criteria:

be between the ages of 18-65 volunteering to participate

Exclusion Criteria:

having any cardiopulmonary disease having cognitive problems being illiterate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Cystic Fibrosis

Inclusion Criteria:

have a confirmed diagnosis of CF stable clinical condition 18-65 ages volunteering to participate

Exclusion Criteria:

having a serious comorbidity that limits mobilization or participation in physical activity being illiterate having cognitive problems being pregnant incomplete answers to surveys
Other: Assessments
Health literacy Anxiety and depression Physical activity Adherence to airway clearance techniques

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health Literacy
Time Frame: 5 minutes
Health literacy will be evaluated with Health Literacy Scale. This scale total score ranges from 25-125 and lower scores show that lower health literacy.
5 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical Activity
Time Frame: 3 minutes
Physical activity will be evaluated with International Physical Activity Questionnaire Short Form.
3 minutes
Adherence to Airway Clearance Tecniques
Time Frame: 1 minute
Frequency of used airway clearance tecniques for a week
1 minute
Anxiety and Depression
Time Frame: 5 minutes
Anxiety and depression will be evaluated with Hospital Anxiety and Depression Scale. A score of 11 or more indicates mood disorders. Anxiety or depression subscales score ranges from 0-21.
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hacettepe University

Investigators

  • Study Director: Naciye Vardar Yağlı, Hacettepe University
  • Study Chair: Ebru Damadoğlu, Hacettepe University
  • Study Chair: Oğuz Karcıoğlu, Hacettepe University
  • Principal Investigator: Aydan Aslı Aksel Uylar, Hacettepe University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 15, 2023

Primary Completion (Actual)

August 15, 2024

Study Completion (Actual)

August 15, 2025

Study Registration Dates

First Submitted

July 19, 2023

First Submitted That Met QC Criteria

July 19, 2023

First Posted (Actual)

July 27, 2023

Study Record Updates

Last Update Posted (Actual)

May 13, 2026

Last Update Submitted That Met QC Criteria

May 9, 2026

Last Verified

February 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GO 22/114

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe